What is Acute Myelogenous Leukemia (AML)?
Acute Myelogenous Leukemia (AML) is a severe type of cancer that affects the bone marrow and blood. In AML, the bone marrow produces abnormal white blood cells called blasts that grow out of control. These cancerous cells crowd out healthy blood cells, disrupting the body’s ability to function properly. AML is one of the most aggressive forms of leukemia, often progressing rapidly without treatment.
Symptoms of AML arise from the imbalance of blood cell types caused by the disease. Healthy blood cells include red blood cells (which carry oxygen), white blood cells (which fight infection), and platelets (which help blood clot). AML disrupts this balance, leading to symptoms like fatigue, infections, and easy bleeding. Early diagnosis is critical, as AML is highly treatable when caught in time.
According to the Mayo Clinic, AML accounts for about 20% of all leukemia cases in adults. It can occur at any age but is most common in older adults.
---Common Causes
- Genetic mutations: Random changes in DNA (e.g., FLT3 or NPM1 gene mutations) can trigger AML. These mutations may occur spontaneously or be inherited. (Source: NIH)
- Chemical exposure: Long-term exposure to benzene (found in industrial solvents and gasoline) is linked to AML. (Source: CDC)
- Radiation: High-dose radiation therapy or atomic bomb exposure increases risk. (Source: WHO)
- Viral infections: Rarely, viruses like Epstein-Barr or SV40 may contribute, though evidence is inconclusive. (Source: Cleveland Clinic)
- Smoking: Smokers have a 2-3 times higher risk of AML due to benzene and other carcinogens. (Source: Cedar Sinai)
- Age: Risk increases sharply after age 65. (Source: Mayo Clinic)
- Family history: A small percentage of cases are linked to inherited genetic conditions. (Source: Blood Journal)
- Immunosuppression: Weakened immune systems from HIV/AIDS or organ transplants may elevate risk. (Source: National Cancer Institute)
- Chemotherapy: Past chemotherapy for other cancers can rarely cause secondary AML. (Source: Blood Disorders Journal)
Associated Symptoms
- Fatigue: Caused by anemia (low red blood cells) or overall disease burden.
- Frequent infections: Low white blood cells reduce the body’s ability to fight germs.
- Easy bruising or bleeding: Low platelets impair clot formation.
- Unexplained weight loss: A common sign of severe illness or metabolic changes.
- Bone pain: Enlarged bone marrow can cause tenderness or aching in bones.
- Swollen lymph nodes: Occurs if leukemia cells spread to lymph tissue.
- Fever or night sweats: May indicate infection or rapid disease progression.
- Shortness of breath: Anemia reduces oxygen delivery to tissues.
- Headaches: Can result from anemia or increased pressure in the skull.
These symptoms often develop quickly and can mimic other illnesses, such as the flu or chronic fatigue. Persistent or worsening symptoms warrant immediate medical evaluation.
---When to See a Doctor
Consult a healthcare provider if you experience any of the following:
- Persistent fever or chills lasting more than 24 hours.
- Unexplained weight loss or weakness lasting over a week.
- Frequent nosebleeds, bruising, or prolonged bleeding from minor cuts.
- Pain in bones that worsens with activity.
- Consistent infections that resist treatment with antibiotics.
- Swelling in multiple body areas (e.g., legs, abdomen).
Even if symptoms seem mild, early diagnosis improves outcomes. The Mayo Clinic emphasizes that prompt evaluation is critical for AML.
---Diagnosis
Diagnosing AML involves several steps to confirm the presence of abnormal blast cells:
- Blood tests: A complete blood count (CBC) may show abnormal white blood cell counts or abnormal cells.
- Bone marrow biopsy: The gold standard for diagnosis. A sample of bone marrow is analyzed for blast cells (>20% indicates AML).
- Cytogenetic testing: Identifies specific genetic mutations (e.g., FLT3) to guide treatment.
- Imaging: X-rays or scans may detect organ damage, though AML typically presents miscellaneous symptoms.
- Lumbar puncture: Rarely used if leukemia cells are found in the spinal fluid.
According to the American Society of Hematology, a definitive diagnosis requires histological confirmation of blast cells in the bone marrow.
---